Aurinia Pharmaceuticals Inc (AUPH)
7.445
-0.32
(-4.12%)
USD |
NASDAQ |
Oct 02, 16:00
7.47
+0.02
(+0.34%)
After-Hours: 20:00
Aurinia Pharmaceuticals Free Cash Flow: -40.32M for June 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -40.32M |
| March 31, 2023 | -65.18M |
| December 31, 2022 | -79.82M |
| September 30, 2022 | -116.20M |
| June 30, 2022 | -141.37M |
| March 31, 2022 | -151.30M |
| December 31, 2021 | -159.19M |
| September 30, 2021 | -131.95M |
| June 30, 2021 | -124.23M |
| March 31, 2021 | -109.10M |
| December 31, 2020 | -77.20M |
| September 30, 2020 | -103.66M |
| June 30, 2020 | -82.77M |
| March 31, 2020 | -73.34M |
| December 31, 2019 | -63.69M |
| September 30, 2019 | -51.88M |
| June 30, 2019 | -51.41M |
| March 31, 2019 | -50.45M |
| December 31, 2018 | -51.68M |
| September 30, 2018 | -46.99M |
| June 30, 2018 | -44.19M |
| March 31, 2018 | -45.88M |
| December 31, 2017 | -41.19M |
| September 30, 2017 | -36.53M |
| June 30, 2017 | -32.20M |
| Date | Value |
|---|---|
| March 31, 2017 | -23.24M |
| December 31, 2016 | -18.74M |
| September 30, 2016 | -19.30M |
| June 30, 2016 | -20.33M |
| March 31, 2016 | -19.00M |
| December 31, 2015 | -17.82M |
| September 30, 2015 | -16.35M |
| June 30, 2015 | -15.16M |
| March 31, 2015 | -15.68M |
| December 31, 2014 | -17.00M |
| September 30, 2014 | -16.20M |
| June 30, 2014 | -13.68M |
| March 31, 2014 | -9.876M |
| December 31, 2013 | -4.728M |
| September 30, 2013 | -2.945M |
| June 30, 2013 | -2.679M |
| March 31, 2013 | -4.973M |
| December 31, 2012 | -6.586M |
| September 30, 2012 | -7.124M |
| June 30, 2012 | -7.029M |
| March 31, 2012 | -5.828M |
| December 31, 2011 | -2.506M |
| September 30, 2011 | -1.960M |
| June 30, 2011 | -2.382M |
| March 31, 2011 | -1.756M |
Free Cash Flow Range, Past 5 Years
-159.19M
Minimum
Dec 2021
-40.32M
Maximum
Jun 2023
-90.78M
Average
-79.82M
Median
Dec 2022
Free Cash Flow Benchmarks
| Acasti Pharma Inc | -16.73M |
| Edesa Biotech Inc | -10.80M |
| Lexaria Bioscience Corp | -5.538M |
| Liminal Biosciences Inc | -27.11M |
| Xenon Pharmaceuticals Inc | -137.24M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.826M |
| Cash from Investing (Quarterly) | -5.608M |
| Cash from Financing (Quarterly) | 1.14M |
| Free Cash Flow Per Share (Quarterly) | -0.0214 |
| Free Cash Flow to Equity (Quarterly) | -3.053M |
| Free Cash Flow to Firm (Quarterly) | -3.053M |
| Free Cash Flow Yield | -3.80% |